Oncopeptides’ Pepaxto reaches end of the line in US after FDA yanks approval fkansteiner Fri, 02/23/2024 – 11:13 More: Oncopeptides' Pepaxto reaches end of the line in US after FDA yanks approval Source: fierce
read moreVenatorx, Melinta’s BARDA-funded antibiotic combo falls short with manufacturing-related rejection zbecker Fri, 02/23/2024 – 11:01 More: Venatorx, Melinta's BARDA-funded antibiotic combo falls short with manufacturing-related rejection Source: fierce
read moreTo BioMarin CEO Alexander Hardy, hemophilia A gene therapy Roctavian needs 3 stars to align aliu Fri, 02/23/2024 – 09:36 More: To BioMarin CEO Alexander Hardy, hemophilia A gene therapy Roctavian needs 3 stars to align Source: fierce
read moreCongressional lawmakers strike back at Biden admin’s ‘march-in’ proposal to corral drug costs fkansteiner Fri, 02/23/2024 – 09:33 More: Congressional lawmakers strike back at Biden admin's 'march-in' proposal to corral drug costs Source: fierce
read moreThe immunosuppressant reduced inflammation in patients with the skin condition after three days More: AbbVie’s Skyrizi shows promise as personalised treatment for psoriasis Source: News
read moreIn England, around 1,100 cases of bowel cancer are caused by the inherited condition every year More: NHS offers preventative bowel cancer screening for patients with Lynch syndrome Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals